Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 56

1.

An Easy and Sensitive Method to Profile the Antibody Specificities of HLA-Specific Memory B Cells.

Karahan GE, Krop J, Wehmeier C, de Vaal Y, Langerak-Langerak J, Roelen DL, Lardy NM, Bemelman FJ, Ten Berge I, Reinders MEJ, van Kooten C, Claas FHJ, Heidt S.

Transplantation. 2018 Nov 9. doi: 10.1097/TP.0000000000002516. [Epub ahead of print]

PMID:
30418423
2.

A paired kidney analysis on the impact of pre-transplant anti-HLA antibodies on graft survival.

Michielsen LA, Wisse BW, Kamburova EG, Verhaar MC, Joosten I, Allebes WA, van der Meer A, Hilbrands LB, Baas MC, Spierings E, Hack CE, van Reekum FE, Bots ML, Drop ACAD, Plaisier L, Seelen MAJ, Sanders JF, Hepkema BG, Lambeck AJ, Bungener LB, Roozendaal C, Tilanus MGJ, Voorter CE, Wieten L, van Duijnhoven EM, Gelens M, Christiaans MHL, van Ittersum FJ, Nurmohamed SA, Lardy NM, Swelsen W, van der Pant KA, van der Weerd NC, Ten Berge IJM, Bemelman FJ, Hoitsma A, van der Boog PJM, de Fijter JW, Betjes MGH, Heidt S, Roelen DL, Claas FH, Otten HG, van Zuilen AD.

Nephrol Dial Transplant. 2018 Oct 25. doi: 10.1093/ndt/gfy316. [Epub ahead of print]

PMID:
30365008
3.

Pretransplant C3d-Fixing Donor-Specific Anti-HLA Antibodies Are Not Associated with Increased Risk for Kidney Graft Failure.

Kamburova EG, Wisse BW, Joosten I, Allebes WA, van der Meer A, Hilbrands LB, Baas MC, Spierings E, Hack CE, van Reekum FE, van Zuilen AD, Verhaar MC, Bots ML, Drop ACAD, Plaisier L, Seelen MAJ, Sanders JS, Hepkema BG, Lambeck AJA, Bungener LB, Roozendaal C, Tilanus MGJ, Voorter CE, Wieten L, van Duijnhoven EM, Gelens MACJ, Christiaans MHL, van Ittersum FJ, Nurmohamed SA, Lardy NM, Swelsen W, van der Pant KAMI, van der Weerd NC, Ten Berge IJM, Bemelman FJ, Hoitsma AJ, van der Boog PJM, de Fijter JW, Betjes MGH, Heidt S, Roelen DL, Claas FH, Otten HG.

J Am Soc Nephrol. 2018 Sep;29(9):2279-2285. doi: 10.1681/ASN.2018020205. Epub 2018 Jul 26.

PMID:
30049681
4.

Mass spectrometry-assisted identification of ADAMTS13-derived peptides presented on HLA-DR and HLA-DQ.

Hrdinová J, Verbij FC, Kaijen PHP, Hartholt RB, van Alphen F, Lardy N, Ten Brinke A, Vanhoorelbeke K, Hindocha PJ, De Groot AS, Meijer AB, Voorberg J, Peyron I.

Haematologica. 2018 Jun;103(6):1083-1092. doi: 10.3324/haematol.2017.179119. Epub 2018 Mar 22.

5.

Differential effects of donor-specific HLA antibodies in living versus deceased donor transplant.

Kamburova EG, Wisse BW, Joosten I, Allebes WA, van der Meer A, Hilbrands LB, Baas MC, Spierings E, Hack CE, van Reekum FE, van Zuilen AD, Verhaar MC, Bots ML, Drop ACAD, Plaisier L, Seelen MAJ, Sanders JSF, Hepkema BG, Lambeck AJA, Bungener LB, Roozendaal C, Tilanus MGJ, Voorter CE, Wieten L, van Duijnhoven EM, Gelens M, Christiaans MHL, van Ittersum FJ, Nurmohamed SA, Lardy NM, Swelsen W, van der Pant KA, van der Weerd NC, Ten Berge IJM, Bemelman FJ, Hoitsma A, van der Boog PJM, de Fijter JW, Betjes MGH, Heidt S, Roelen DL, Claas FH, Otten HG.

Am J Transplant. 2018 Sep;18(9):2274-2284. doi: 10.1111/ajt.14709. Epub 2018 Apr 16.

6.

Human and Rhesus Macaque KIR Haplotypes Defined by Their Transcriptomes.

Bruijnesteijn J, van der Wiel MKH, Swelsen WTN, Otting N, de Vos-Rouweler AJM, Elferink D, Doxiadis GG, Claas FHJ, Lardy NM, de Groot NG, Bontrop RE.

J Immunol. 2018 Mar 1;200(5):1692-1701. doi: 10.4049/jimmunol.1701480. Epub 2018 Jan 22.

PMID:
29358278
7.

Comparative profiling of HLA-DR and HLA-DQ associated factor VIII peptides presented by monocyte-derived dendritic cells.

Peyron I, Hartholt RB, Pedró-Cos L, van Alphen F, Brinke AT, Lardy N, Meijer AB, Voorberg J.

Haematologica. 2018 Jan;103(1):172-178. doi: 10.3324/haematol.2017.175083. Epub 2017 Oct 12.

8.

How can we reduce costs of solid-phase multiplex-bead assays used to determine anti-HLA antibodies?

Kamburova EG, Wisse BW, Joosten I, Allebes WA, van der Meer A, Hilbrands LB, Baas MC, Spierings E, Hack CE, van Reekum FE, van Zuilen AD, Verhaar M, Bots ML, Drop AC, Plaisier L, Seelen MA, Sanders JS, Hepkema BG, Lambeck AJ, Bungener LB, Roozendaal C, Tilanus MG, Vanderlocht J, Voorter CE, Wieten L, van Duijnhoven EM, Gelens M, Christiaans MH, van Ittersum FJ, Nurmohamed A, Lardy NM, Swelsen W, van der Pant KA, van der Weerd NC, Ten Berge IJ, Bemelman FJ, Hoitsma A, van der Boog PJ, de Fijter JW, Betjes MG, Heidt S, Roelen DL, Claas FH, Otten HG.

HLA. 2016 Sep;88(3):110-9. doi: 10.1111/tan.12860. Epub 2016 Aug 18.

PMID:
27534609
9.

Underdiagnosing of antibody-mediated transfusion-related acute lung injury: evaluation of cellular-based versus bead-based techniques.

van Stein D, Beckers EA, Peters AL, Porcelijn L, Middelburg RA, Lardy NM, van Rhenen DJ, Vlaar AP.

Vox Sang. 2016 Jul;111(1):71-8. doi: 10.1111/vox.12383. Epub 2016 Mar 18.

PMID:
26991993
10.

CD4+ T cells from patients with acquired thrombotic thrombocytopenic purpura recognize CUB2 domain-derived peptides.

Verbij FC, Turksma AW, de Heij F, Kaijen P, Lardy N, Fijnheer R, Sorvillo N, ten Brinke A, Voorberg J.

Blood. 2016 Mar 24;127(12):1606-9. doi: 10.1182/blood-2015-10-668053. Epub 2016 Jan 8.

11.

Somatic Variation of T-Cell Receptor Genes Strongly Associate with HLA Class Restriction.

Klarenbeek PL, Doorenspleet ME, Esveldt RE, van Schaik BD, Lardy N, van Kampen AH, Tak PP, Plenge RM, Baas F, de Bakker PI, de Vries N.

PLoS One. 2015 Oct 30;10(10):e0140815. doi: 10.1371/journal.pone.0140815. eCollection 2015.

12.

The PROCARE consortium: toward an improved allocation strategy for kidney allografts.

Otten HG, Joosten I, Allebes WA, van der Meer A, Hilbrands LB, Baas M, Spierings E, Hack CE, van Reekum F, van Zuilen AD, Verhaar MC, Bots ML, Seelen MA, Sanders JS, Hepkema BG, Lambeck AJ, Bungener LB, Roozendaal C, Tilanus MG, Vanderlocht J, Voorter CE, Wieten L, van Duijnhoven E, Gelens M, Christiaans M, van Ittersum F, Nurmohamed A, Lardy NM, Swelsen WT, van Donselaar-van der Pant KA, van der Weerd NC, Ten Berge IJ, Bemelman FJ, Hoitsma AJ, de Fijter JW, Betjes MG, Roelen DL, Claas FH.

Transpl Immunol. 2014 Oct;31(4):184-90. doi: 10.1016/j.trim.2014.09.008. Epub 2014 Oct 1.

PMID:
25258025
13.

Minor H antigen matches and mismatches are equally distributed among recipients with or without complications after HLA identical sibling renal transplantation.

Dierselhuis MP, Spierings E, Drabbels J, Hendriks M, Alaez C, Alberú J, Alvarez MB, Burlingham W, Campos E, Christiaans M, Claas F, Fasano ME, Gerbase-Delima M, Gervais T, Gorodezky C, Larriba J, Lardy NM, Latinne D, Morales-Buenrostro LE, Moreno MJ, Oguz F, Opelz G, Sergeant R, Tambutti M, Teper S, Tilanus M, Turkmen A, Warrens AN, Weimar W, Goulmy E.

Tissue Antigens. 2013 Nov;82(5):312-6. doi: 10.1111/tan.12209. Epub 2013 Oct 4.

PMID:
24116658
14.

Extensive variation in gene copy number at the killer immunoglobulin-like receptor locus in humans.

Vendelbosch S, de Boer M, Gouw RA, Ho CK, Geissler J, Swelsen WT, Moorhouse MJ, Lardy NM, Roos D, van den Berg TK, Kuijpers TW.

PLoS One. 2013 Jun 28;8(6):e67619. doi: 10.1371/journal.pone.0067619. Print 2013.

15.

The unusual DRB1*08:01 haplotype carrying DRB3*02:02 confirmed in a Dutch family.

Swelsen WT, Hartog KS, Ranzijn CM, Lardy NM.

Tissue Antigens. 2013 Aug;82(2):122-4. doi: 10.1111/tan.12141. Epub 2013 Jun 7. No abstract available.

PMID:
23742216
16.

Identification of two new HLA class II alleles: DRB1*01:50 and DQB1*05:18.

Swelsen WT, Hartog KS, Lardy NM.

Tissue Antigens. 2013 Jul;82(1):78-9. doi: 10.1111/tan.12124. Epub 2013 Apr 24.

PMID:
23611661
17.

Characterization of three new HLA-B alleles: B*35:05:03, B*52:29 and B*57:01:13.

Swelsen WT, Hartog KS, Poell B, Varlack SV, Lardy NM.

Tissue Antigens. 2012 Sep;80(3):270-1. doi: 10.1111/j.1399-0039.2012.01903.x. Epub 2012 Jun 13.

PMID:
22690825
18.

Characteristics of alloreactive T cells measured before renal transplantation.

van de Berg PJ, Yong SL, Koch SD, Lardy N, van Donselaar-van der Pant KA, Florquin S, Bemelman FJ, van Lier RA, ten Berge IJ.

Clin Exp Immunol. 2012 May;168(2):241-50. doi: 10.1111/j.1365-2249.2011.04551.x.

19.

Allo-exposure status and leucocyte antibody positivity of blood donors show a similar relation with TRALI.

Middelburg RA, Beckers EA, Porcelijn L, Lardy N, Wiersum-Osselton JC, Schipperus MR, Vrielink H, Briët E, van der Bom JG.

Transfus Med. 2012 Apr;22(2):128-32. doi: 10.1111/j.1365-3148.2012.01140.x. Epub 2012 Mar 1.

PMID:
22380759
20.

Characterization of a new allele: HLA-A*03:134.

Swelsen WT, Poell B, Hartog KS, Lardy NM.

Tissue Antigens. 2012 Apr;79(4):309-10. doi: 10.1111/j.1399-0039.2012.01846.x. Epub 2012 Feb 10.

PMID:
22320675
21.

Prevalence of leucocyte antibodies in the Dutch donor population.

Middelburg RA, Porcelijn L, Lardy N, Briët E, Vrielink H.

Vox Sang. 2011 Apr;100(3):327-35. doi: 10.1111/j.1423-0410.2010.01420.x. Epub 2010 Oct 15.

PMID:
20946548
22.

The divergent clinical presentations of transfusion-related acute lung injury illustrated by two case reports.

Vlaar AP, Porcelijn L, van Rooijen-Schreurs IH, Lardy NM, Kersten MJ, Juffermans NP.

Med Sci Monit. 2010 Oct;16(10):CS129-34.

PMID:
20885357
23.

Ten-yr results of the trans-Atlantic kidney transplant airlift between the Dutch Caribbean and the Netherlands.

Minnee RC, Lardy N, Ajubi N, Idu MM, Kock RV, Legemate DA, van Donselaar-van der Pant KA, Bemelman FJ.

Clin Transplant. 2011 Mar-Apr;25(2):302-7. doi: 10.1111/j.1399-0012.2010.01239.x.

PMID:
20331691
24.

High resolution definition of HLA-DRB haplotypes by a simplified microsatellite typing technique.

Doxiadis GG, de Groot N, Dauber EM, van Eede PH, Fae I, Faner R, Fischer G, Grubic Z, Lardy NM, Mayr W, Palou E, Swelsen W, Stingl K, Doxiadis II, Bontrop RE.

Tissue Antigens. 2009 Dec;74(6):486-93. doi: 10.1111/j.1399-0039.2009.01369.x. Epub 2009 Sep 24.

PMID:
19778321
25.

Pre-kidney-transplant blood transfusions do not improve transplantation outcome: a Dutch national study.

Aalten J, Bemelman FJ, van den Berg-Loonen EM, Claas FH, Christiaans MH, de Fijter JW, Hepkema BG, Hené RJ, van der Heide JJ, van Hooff JP, Lardy NM, Lems SP, Otten HG, Weimar W, Allebes WA, Hoitsma AJ.

Nephrol Dial Transplant. 2009 Aug;24(8):2559-66. doi: 10.1093/ndt/gfp233. Epub 2009 May 27.

PMID:
19474284
26.

[Humoral immunity and kidney transplantation. Possibilities and desensitizing treatment].

Rowshani AT, Lardy NM, Surachno JS, ten Berge RJ.

Ned Tijdschr Geneeskd. 2009 Mar 28;153(13):612-6. Dutch. No abstract available.

PMID:
19408538
27.

Humoral immunity in renal transplantation: clinical significance and therapeutic approach.

Rowshani AT, Bemelman FJ, Lardy NM, Ten Berge IJ.

Clin Transplant. 2008 Nov-Dec;22(6):689-99. doi: 10.1111/j.1399-0012.2008.00872.x. Epub 2008 Jul 31. Review.

PMID:
18673372
28.

Cytokine gene polymorphisms in the Dutch population.

Skorpil N, Kolesár L, Striz I, Lardy NM, Slavcev A.

Int J Immunogenet. 2007 Apr;34(2):87-90.

PMID:
17373932
29.

CD103 is a marker for alloantigen-induced regulatory CD8+ T cells.

Uss E, Rowshani AT, Hooibrink B, Lardy NM, van Lier RA, ten Berge IJ.

J Immunol. 2006 Sep 1;177(5):2775-83.

30.

HLA class II genotype and factor VIII inhibitors in mild haemophilia A patients with an Arg593 to Cys mutation.

Bril WS, MacLean PE, Kaijen PH, van den Brink EN, Lardy NM, Fijnvandraat K, Peters M, Voorberg J.

Haemophilia. 2004 Sep;10(5):509-14.

PMID:
15357778
31.

Cross-reactivity of cytomegalovirus-specific CD8+ T cells to allo-major histocompatibility complex class I molecules.

Gamadia LE, Remmerswaal EB, Surachno S, Lardy NM, Wertheim-van Dillen PM, van Lier RA, ten Berge IJ.

Transplantation. 2004 Jun 27;77(12):1879-85.

PMID:
15223907
32.

Prenatal HLA-matching to determine suitability for allogeneic bone marrow transplantation.

van den Berg H, Verjaal M, Boer K, Lardy NM.

Bone Marrow Transplant. 2000 Mar;25(6):579-81.

33.

Presence of the DRB4*0103102N null allele in different DRB1*04-positive individuals.

Voorter CE, Lardy NM, van den Berg-Loonen EM.

Tissue Antigens. 2000 Jan;55(1):37-43.

PMID:
10703606
34.

Clinical features of spondyloarthropathy in Chinese and native Indonesians.

Mardjuadi A, Nasution AR, Kunmartini S, Lardy NM, Sudarsono D, Feltkamp TE.

Clin Rheumatol. 1999;18(6):442-5.

PMID:
10638767
35.

Evidence that HLA-B*2706 is not protective against spondyloarthropathy.

Sudarsono D, Hadi S, Mardjuadi A, Nasution AR, Dekker-Saeys AJ, Breur-Vriesendorp BS, Lardy NM, Feltkamp TE.

J Rheumatol. 1999 Jul;26(7):1534-6.

PMID:
10405941
36.

HLA-DRB4 gene encoded HLA-DR53 specificity segregating with the HLA-DR7, -DQ9 haplotype: unusual association.

Lardy NM, van der Horst AR, van de Weerd MJ, de Waal LP, Bontrop RE.

Hum Immunol. 1998 Feb;59(2):115-8.

PMID:
9536434
37.

Full-length cDNA nucleotide sequence of a serologically undetectable HLA-DQA1 allele: HLA-DQA1*"LA".

Lardy NM, Otting N, van der Horst AR, Bontrop RE, de Waal LP.

Tissue Antigens. 1997 Oct;50(4):334-9.

PMID:
9349615
38.

Antinuclear antibody and HLA-B27 positive uveitis: combination of two diseases?

Bosch-Driessen EH, Lardy NM, Rothova A.

Br J Ophthalmol. 1997 Sep;81(9):771-3.

39.

Influence of HLA-DRB1* incompatibility on the occurrence of rejection episodes and graft survival in serologically HLA-DR-matched renal transplant combinations.

Lardy NM, van der Horst AR, ten Berge IJ, Surachno S, Wilmink JM, de Waal LP.

Transplantation. 1997 Aug 27;64(4):612-6.

PMID:
9293875
40.

Full-length cDNA nucleotide sequence of the HLA-B*4202 allele.

Lardy NM, Otting N, van de Weerd MJ, van de Horst AR, Waal LP, Bontrop RE.

Tissue Antigens. 1997 Jul;50(1):83-4. No abstract available.

PMID:
9243763
41.

HLA-B27 subtypes positively and negatively associated with spondyloarthropathy.

Nasution AR, Mardjuadi A, Kunmartini S, Suryadhana NG, Setyohadi B, Sudarsono D, Lardy NM, Feltkamp TE.

J Rheumatol. 1997 Jun;24(6):1111-4.

PMID:
9195518
42.

5' regulatory nucleotide sequence of an HLA-A*0101null allele.

Lardy NM, Otting N, van der Horst AR, Bontrop RE, de Waal LP.

Immunogenetics. 1997;46(2):152-5.

PMID:
9162102
43.

Seronegative spondyloarthropathies and HLA-B27 subtyes: a study in Asian Indians.

Kanga U, Mehra NK, Larrea CL, Lardy NM, Kumar A, Feltkamp TE.

Clin Rheumatol. 1996 Jan;15 Suppl 1:13-8.

PMID:
8835495
44.

Histoincompatibilities in ABDR-matched unrelated donor recipient combinations.

Rufer N, Tiercy JM, Breur-Vriesendorp B, Gauchat-Feiss D, Shi X, Slavcev A, Lardy N, Speiser D, Gratwohl A, Chapuis B, et al.

Bone Marrow Transplant. 1995 Nov;16(5):641-6.

PMID:
8547860
45.

HLA-B35-subtype mismatches in ABDR serologically matched unrelated donor-recipient pairs.

Rufer N, Breur-Vriesendorp B, Tiercy JM, Gauchat-Feiss D, Shi X, Slavcev A, Lardy N, Chapuis B, Gratwohl A, Speiser D, et al.

Hum Immunol. 1994 Sep;41(1):96-101.

PMID:
7836072
46.
47.

Complete nucleotide sequence of HLA-B*0703, a B7 variant (BPOT).

Bergmans AM, Tijssen H, Lardy N, Reekers P.

Hum Immunol. 1993 Oct;38(2):159-62.

PMID:
8106270
48.

cis-acting regulatory elements abrogate allele-specific HLA class I gene expression in healthy individuals.

Lardy NM, Bakas RM, van der Horst AR, van Twuyver E, Bontrop RE, de Waal LP.

J Immunol. 1992 Apr 15;148(8):2572-7.

PMID:
1560211
49.

Resistance to collagen-induced arthritis in a nonhuman primate species maps to the major histocompatibility complex class I region.

Bakker NP, van Erck MG, Otting N, Lardy NM, Noort RC, 't Hart BA, Jonker M, Bontrop RE.

J Exp Med. 1992 Apr 1;175(4):933-7.

50.

HLA-A29 subtypes and birdshot chorioretinopathy.

de Waal LP, Lardy NM, van der Horst AR, Baarsma GS, Kijlstra A, Noens L, Priem HA.

Immunogenetics. 1992;35(1):51-3. No abstract available.

PMID:
1729172

Supplemental Content

Support Center